Skip to main content

and
  1. No Access

    Article

    Effect of Chronic Treatment with D2 Allosteric Modulator PAOPA on the Expression of Cerebral Dopamine Neurotrophic Factor (CDNF) in Select Brain Regions

    Impairment in dopaminergic pathways has been implicated in several detrimental neuropsychiatric and neurodegenerative disorders, including schizophrenia and Parkinson’s disease. Current approved therapeutic dr...

    Yuxin Tian, Ritesh Daya, Jayant Bhandari in International Journal of Peptide Research … (2021)